» Articles » PMID: 36514216

Circ-BPTF Serves As a MiR-486-5p Sponge to Regulate CEMIP and Promotes Hypoxic Pulmonary Arterial Smooth Muscle Cell Proliferation in COPD

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Hypoxia plays a crucial role in pulmonary vascular remodelling at the early stage of chronic obstructive pulmonary disease (COPD). Circle RNA (circRNA) has been identified to play a critical role in multiple diseases. However, the role of circRNAs in pulmonary vascular remodelling in COPD remains unclear. In this study, we aim to investigate the role of circRNAs in pulmonary arterial smooth muscle cell proliferation and pulmonary vascular remodelling in COPD. COPD patients show lower partial pressure of arterial oxygen and pulmonary arterial remodeling as compared with controls. circRNA microarray and real-time PCR analyses show significantly higher level of circ-BPTF and lower miR-486-5p level in the pulmonary arteries of COPD patients as compared with controls. Hypoxia suppresses miR-486-5p expression but promotes expressions of circ-BPTF and cell migration inducing protein (CEMIP) in human pulmonary arterial smooth muscle cells (PASMCs) . Loss- and gain-of-function experiments show that circ-BPTF promotes PASMC proliferation . Moreover, luciferase reporter assay results indicate that circ-BPTF regulates PASMC proliferation by acting as an miR-486-5p sponge. is identified as a candidate target gene of miR-486-5p by luciferase reporter assay. Overall, our study shows that circ-BPTF serves as a miR-486-5p sponge to regulate CEMIP and promote hypoxic PASMC proliferation in pulmonary vascular remodelling in COPD.

Citing Articles

Artemisia capillaris with two novel active compounds, Kawarayomogin I and II, inhibits HYBID (KIAA1199) expression as well as hyaluronic acid degradation.

Biswas K, Kawai Y, Nakagawa S, Kanai K, Kojima H, Masutani T Sci Rep. 2025; 15(1):2042.

PMID: 39820064 PMC: 11739587. DOI: 10.1038/s41598-025-86320-4.


Circular RNAs in human diseases.

Wang Y, Zhang J, Yang Y, Liu Z, Sun S, Li R MedComm (2020). 2024; 5(9):e699.

PMID: 39239069 PMC: 11374765. DOI: 10.1002/mco2.699.


Exploring the Multifaceted Biologically Relevant Roles of circRNAs: From Regulation, Translation to Biomarkers.

Hoque P, Romero B, Akins R, Batish M Cells. 2023; 12(24).

PMID: 38132133 PMC: 10741722. DOI: 10.3390/cells12242813.


Circular RNAs: emerging players in asthma and COPD.

Liu X, Ali M, Dua K, Mao Y, Liu J Front Cell Dev Biol. 2023; 11:1267792.

PMID: 38078005 PMC: 10704470. DOI: 10.3389/fcell.2023.1267792.


circRNA-miRNA-mRNA Deregulated Network in Ischemic Heart Failure Patients.

Made A, Bibi A, Garcia-Manteiga J, Tascini A, Piella S, Tikhomirov R Cells. 2023; 12(21).

PMID: 37947656 PMC: 10648415. DOI: 10.3390/cells12212578.


References
1.
Zeng D, Xu G, Lei W, Wang R, Wang C, Huang J . Suppression of cyclin D1 by plasmid-based short hairpin RNA ameliorated experimental pulmonary vascular remodeling. Microvasc Res. 2013; 90:144-9. DOI: 10.1016/j.mvr.2013.07.012. View

2.
Lei Y, Yang Q, Nie Y, Wan J, Deng M . Small-molecule inhibitor LF3 restrains the development of pulmonary hypertension through the Wnt/β-catenin pathway. Acta Biochim Biophys Sin (Shanghai). 2021; 53(10):1277-1289. DOI: 10.1093/abbs/gmab103. View

3.
Kong Y, Li Y, Luo Y, Zhu J, Zheng H, Gao B . circNFIB1 inhibits lymphangiogenesis and lymphatic metastasis via the miR-486-5p/PIK3R1/VEGF-C axis in pancreatic cancer. Mol Cancer. 2020; 19(1):82. PMC: 7197141. DOI: 10.1186/s12943-020-01205-6. View

4.
Nathan S, Barbera J, Gaine S, Harari S, Martinez F, Olschewski H . Pulmonary hypertension in chronic lung disease and hypoxia. Eur Respir J. 2018; 53(1). PMC: 6351338. DOI: 10.1183/13993003.01914-2018. View

5.
Hanna J, Garcia M, Lardennois A, Leavey P, Maglic D, Fagnan A . PAX3-FOXO1 drives miR-486-5p and represses miR-221 contributing to pathogenesis of alveolar rhabdomyosarcoma. Oncogene. 2018; 37(15):1991-2007. PMC: 5895609. DOI: 10.1038/s41388-017-0081-3. View